News

The FDA expanded the approval of the SONU Band to include the treatment of patients aged 12 years and older with moderate to severe nasal congestion due to allergic or nonallergic rhinitis, according ...
Law enforcement officers have dismantled the largest illegal production of anabolic steroids in Ukraine, disguised as imported medical drugs for athletes, as reported by the Prosecutor General's ...
Three studies compared corticosteroid (equivalent ≤ 8 mg dexamethasone) to placebo. One study compared corticosteroid (dexamethasone 4 mg) to an active comparator (modafinil 100 mg). ...
Long-acting muscarinic antagonists, as add-on therapy to inhaled corticosteroids, improve lung function parameters and reduce ...
SAN FRANCISCO — About half of patients with asthma on tezepelumab had discontinued their daily maintenance oral corticosteroid doses by 52 weeks, according to an abstract presented at the ...
The proportion able to discontinue the corticosteroid entirely without loss of asthma control was 32.2% by week 28 and 50.3% at week 52, David J. Jackson, MBBS, PhD, of King's College London ...
Topical and subconjunctival corticosteroids are some of the most effective and compelling treatment options in ocular inflammatory diseases. A systematic review of literature indexed by Ovid MEDLINE & ...
Inhaled corticosteroids (ICS) are a mainstay in reducing airway inflammation and are considered the most effective treatment in children with persistent asthma. 1 Few ICS options are approved for use ...
West Syndrome Market Outlook 2025-2035: The 7 major West syndrome market reached a value of USD 212.9 Million in 2024. Looking forward, IMARC Group expects the 7MM to reach USD 328.2 Million by 2035, ...
For patients experiencing septic shock, the guideline offers a conditional recommendation for administering corticosteroids at a daily dose of less than 400 mg hydrocortisone equivalent. This decision ...
Inhaled corticosteroids (ICS) are commonly used for the treatment of asthma and chronic obstructive pulmonary disease (COPD), though their effectiveness for the latter remains controversial.1, 2 ...
Filgotinib may be an option for patients with various types of uveitis who do not respond to treatment with conventional methods, such as prednisone or a corticosteroid, according to trial results ...